Inspire Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of ophthalmic products, is being acquired by Merck & Co., commonly known as MSD outside the U.S. and Canada. The acquisition is being valued at approximately $430 million.
Continue reading ‘Merck & Co. to Acquire Inspire Pharmaceuticals’
In research conducted by the University at Buffalo, it has been proven that a low dosage of insulin has the ability to restrict the expression in the blood of four precursor proteins involved in the pathogenesis of Alzheimer’s disease. Research done by endocrinologists at the University at Buffalo indicates that insulin might have a powerful and new role to play in combating Alzheimer’s disease.
Continue reading ‘Insulin Might be Potential Cure for Alzheimer’s’
A new development in cancer technology has made it possible for researchers to identify cancer cells with carbon nanotubes. In recent announcement, a Harvard bioengineer and an MIT aeronautical engineer have developed a novel device that can identify single cancer cells in a blood sample, thus making it possible for doctors to quickly determine whether cancer has spread from its original site.
A biochemist from the Purdue University has proved that with the use of nanotechnology, it is possible to understand whether or not cancer medicines are going to hit their targets, and thus lower the amount of side effects these drugs have. W. Andy Tao, an associate professor of biochemistry analytical chemistry, has produced a nanopolymer that has the capability to be coated with medicines, enter the cells and then removed to understand which are the proteins in the cells that the drug has entered into. Since these nanopolymers are soluble in water, they make a better delivery system for drugs that do not dissolve in water very efficiently.
Continue reading ‘Dealing with Cancer Side Effects with Nanopolymers’
The U.S. Food and Drug Administration have recently approved the once-daily tablet formulation of Boehringer Ingelheim Pharmaceuticals’ Viramune® (nevirapine) drug for treating HIV-1. The extended-release Viramune XR™ is a once-daily, 400 mg formulation of nevirapine that has been approved for usage along with other antiretroviral agents in adults.
Generally it has been found that women with very low body fat, including runners and dancers, as well as women with eating disorders, are likely to develop hypothalamic amenorrhea. This is a condition in which the menstrual periods cease and triggers off many serious problems such as infertility and osteoporosis.
Continue reading ‘Lack of Leptin May Lead to Infertility in Women’
Research at the University of New Mexico (UNM), Brown University, and House Ear Institute (HEI) have shown that if the herpes virus remains in a latent form inside never cells in a person, that person is most likely to develop some form of cognitive decline, usually associated with Alzheimer’s disease.
New research has shown that oxygen can actually be used as a source for curing cancer. Research conducted by a team at the University of Washington and Washington State University and recently reported in the journal Anticancer Research, has shown that an environment of pure oxygen at three-and-a-half times normal air pressure can add significantly to the efficiency of a natural compound already shown to kill cancerous cells.
New research from Emory/Georgia Tech Predictive Health Institute has proven that a deficiency of vitamin D, even in generally healthy people, is likely to cause stiffer arteries and also an inability of blood vessels to relax.
Continue reading ‘Research Reveals Link Between Vitamin D and Stiff Arteries’
In a new breakthrough in the treatment for epilepsy, researchers from the Vanderbilt University have identified a new gene that can impact a person’s risk for developing epilepsy. The findings are likely to help molecular diagnostic tools and also lead to the development of novel therapeutic targets for epilepsy.
Continue reading ‘Risk of Epilepsy Influenced by Potassium Channel Gene’
You are currently browsing the weblog archives for the Disease category.
Biotech Trading Signals Pharma News Biotech News